The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals and access to digital therapies, as well as the growing importance of technologies such as artificial intelligence (AI), the Internet of Things (IoT), augmented reality (AR), robotics and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Wearable Tech in Healthcare: Ambulatory infusion device.
According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.
Ambulatory infusion device is a key innovation area in wearable tech
An ambulatory infusion device is a small pump powered by battery to deliver medicine, such as chemotherapy or antibiotics, into the body in a controlled manner.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of ambulatory infusion device.
Key players in ambulatory infusion device – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to ambulatory infusion device
Company | Total patents (2010 - 2021) | Premium intelligence on the world's largest companies |
DEKA Research and Development | 248 | Unlock company profile |
Becton Dickinson and Co | 101 | Unlock company profile |
Fresenius & Co | 78 | Unlock company profile |
Serres | 35 | Unlock company profile |
Bayer | 26 | Unlock company profile |
Chiaro Technology | 25 | Unlock company profile |
Olle Larsson Holding | 21 | Unlock company profile |
Moog | 19 | Unlock company profile |
Osprey Medical | 18 | Unlock company profile |
Fisher & Paykel Healthcare | 17 | Unlock company profile |
Air Liquide | 16 | Unlock company profile |
Optiscan Biomedical | 15 | Unlock company profile |
Baxter International | 14 | Unlock company profile |
Getinge | 12 | Unlock company profile |
Trudell Medical International | 11 | Unlock company profile |
3M | 11 | Unlock company profile |
F. Hoffmann-La Roche | 11 | Unlock company profile |
Art Medical | 9 | Unlock company profile |
Hybernia Medical | 9 | Unlock company profile |
Medrad | 6 | Unlock company profile |
Braidlock | 6 | Unlock company profile |
Source: GlobalData Patent Analytics
DEKA Research and Development, Becton Dickinson and Fresenius are the leading patent filers in the wearable tech ambulatory infusion device market. Some other leading patent filers include Serres and Olle Larsson.
In terms of application diversity, Optiscan Biomedical, and Getinge lead, followed by Braidlock. With regards to geographic reach, 3M holds the top position, followed by Olle Larsson and Hybernia Medical.
Ambulatory infusion devices play an important role in drug delivery in a variety of clinical settings. The devices are becoming more popular due to their introduction as part of front-line patient therapy.
To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Healthcare.
More Data Insights
View More